Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: A CO-MED report

Herng Nieng Chan, A. John Rush, Andrew A. Nierenberg, Madhukar Trivedi, Stephen R. Wisniewski, G. K. Balasubramani, Edward S. Friedman, Bradley N. Gaynes, Lori Davis, David Morris, Maurizio Fava

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The objective of this paper was to determine whether the presence of more vs. fewer anxious symptom features, at baseline, are associated with other clinical features and treatment outcomes in out-patients with major depressive disorder (MDD). This single-blind, randomized trial enrolled 665 MDD out-patients to compare the efficacy of two antidepressant medication combinations against escitalopram after 12-wk acute treatment and follow-up (total 28 wk). The sample was divided into those with greater (vs. fewer) anxiety features using the anxiety/somatization subscale of the baseline 17-item Hamilton Rating Scale for Depression. Baseline sociodemographic and clinical features, treatment features and outcomes compared these two groups. Overall, 74.7% of participants met the threshold for anxious features. They were more likely to be female, have other concurrent anxiety disorders, more severe depression, more lethargic and melancholic features and poorer cognitive and physical functioning, quality of life and work and social adjustment. In acute treatment, participants with anxious features received comparatively higher doses of mirtazapine and venlafaxine and reported more side-effects. The groups with and without anxious features did not differ in treatment outcomes and side-effect burden. Despite being associated with a distinct clinical profile, baseline anxious features were not clinically useful in predicting acute treatment outcomes or differential treatment response.

Original languageEnglish (US)
Pages (from-to)1387-1399
Number of pages13
JournalInternational Journal of Neuropsychopharmacology
Volume15
Issue number10
DOIs
StatePublished - Nov 2012

Fingerprint

Carbon Monoxide
Outpatients
Major Depressive Disorder
Anxiety
Depression
Social Adjustment
Citalopram
Anxiety Disorders
Antidepressive Agents
Therapeutics
Quality of Life

Keywords

  • Anxiety
  • depression
  • outcomes
  • treatment prediction

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Psychiatry and Mental health

Cite this

Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms : A CO-MED report. / Chan, Herng Nieng; John Rush, A.; Nierenberg, Andrew A.; Trivedi, Madhukar; Wisniewski, Stephen R.; Balasubramani, G. K.; Friedman, Edward S.; Gaynes, Bradley N.; Davis, Lori; Morris, David; Fava, Maurizio.

In: International Journal of Neuropsychopharmacology, Vol. 15, No. 10, 11.2012, p. 1387-1399.

Research output: Contribution to journalArticle

Chan, HN, John Rush, A, Nierenberg, AA, Trivedi, M, Wisniewski, SR, Balasubramani, GK, Friedman, ES, Gaynes, BN, Davis, L, Morris, D & Fava, M 2012, 'Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: A CO-MED report', International Journal of Neuropsychopharmacology, vol. 15, no. 10, pp. 1387-1399. https://doi.org/10.1017/S1461145711001660
Chan, Herng Nieng ; John Rush, A. ; Nierenberg, Andrew A. ; Trivedi, Madhukar ; Wisniewski, Stephen R. ; Balasubramani, G. K. ; Friedman, Edward S. ; Gaynes, Bradley N. ; Davis, Lori ; Morris, David ; Fava, Maurizio. / Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms : A CO-MED report. In: International Journal of Neuropsychopharmacology. 2012 ; Vol. 15, No. 10. pp. 1387-1399.
@article{9d13ae40cd314a60b90577fb1136963d,
title = "Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: A CO-MED report",
abstract = "The objective of this paper was to determine whether the presence of more vs. fewer anxious symptom features, at baseline, are associated with other clinical features and treatment outcomes in out-patients with major depressive disorder (MDD). This single-blind, randomized trial enrolled 665 MDD out-patients to compare the efficacy of two antidepressant medication combinations against escitalopram after 12-wk acute treatment and follow-up (total 28 wk). The sample was divided into those with greater (vs. fewer) anxiety features using the anxiety/somatization subscale of the baseline 17-item Hamilton Rating Scale for Depression. Baseline sociodemographic and clinical features, treatment features and outcomes compared these two groups. Overall, 74.7{\%} of participants met the threshold for anxious features. They were more likely to be female, have other concurrent anxiety disorders, more severe depression, more lethargic and melancholic features and poorer cognitive and physical functioning, quality of life and work and social adjustment. In acute treatment, participants with anxious features received comparatively higher doses of mirtazapine and venlafaxine and reported more side-effects. The groups with and without anxious features did not differ in treatment outcomes and side-effect burden. Despite being associated with a distinct clinical profile, baseline anxious features were not clinically useful in predicting acute treatment outcomes or differential treatment response.",
keywords = "Anxiety, depression, outcomes, treatment prediction",
author = "Chan, {Herng Nieng} and {John Rush}, A. and Nierenberg, {Andrew A.} and Madhukar Trivedi and Wisniewski, {Stephen R.} and Balasubramani, {G. K.} and Friedman, {Edward S.} and Gaynes, {Bradley N.} and Lori Davis and David Morris and Maurizio Fava",
year = "2012",
month = "11",
doi = "10.1017/S1461145711001660",
language = "English (US)",
volume = "15",
pages = "1387--1399",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "10",

}

TY - JOUR

T1 - Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms

T2 - A CO-MED report

AU - Chan, Herng Nieng

AU - John Rush, A.

AU - Nierenberg, Andrew A.

AU - Trivedi, Madhukar

AU - Wisniewski, Stephen R.

AU - Balasubramani, G. K.

AU - Friedman, Edward S.

AU - Gaynes, Bradley N.

AU - Davis, Lori

AU - Morris, David

AU - Fava, Maurizio

PY - 2012/11

Y1 - 2012/11

N2 - The objective of this paper was to determine whether the presence of more vs. fewer anxious symptom features, at baseline, are associated with other clinical features and treatment outcomes in out-patients with major depressive disorder (MDD). This single-blind, randomized trial enrolled 665 MDD out-patients to compare the efficacy of two antidepressant medication combinations against escitalopram after 12-wk acute treatment and follow-up (total 28 wk). The sample was divided into those with greater (vs. fewer) anxiety features using the anxiety/somatization subscale of the baseline 17-item Hamilton Rating Scale for Depression. Baseline sociodemographic and clinical features, treatment features and outcomes compared these two groups. Overall, 74.7% of participants met the threshold for anxious features. They were more likely to be female, have other concurrent anxiety disorders, more severe depression, more lethargic and melancholic features and poorer cognitive and physical functioning, quality of life and work and social adjustment. In acute treatment, participants with anxious features received comparatively higher doses of mirtazapine and venlafaxine and reported more side-effects. The groups with and without anxious features did not differ in treatment outcomes and side-effect burden. Despite being associated with a distinct clinical profile, baseline anxious features were not clinically useful in predicting acute treatment outcomes or differential treatment response.

AB - The objective of this paper was to determine whether the presence of more vs. fewer anxious symptom features, at baseline, are associated with other clinical features and treatment outcomes in out-patients with major depressive disorder (MDD). This single-blind, randomized trial enrolled 665 MDD out-patients to compare the efficacy of two antidepressant medication combinations against escitalopram after 12-wk acute treatment and follow-up (total 28 wk). The sample was divided into those with greater (vs. fewer) anxiety features using the anxiety/somatization subscale of the baseline 17-item Hamilton Rating Scale for Depression. Baseline sociodemographic and clinical features, treatment features and outcomes compared these two groups. Overall, 74.7% of participants met the threshold for anxious features. They were more likely to be female, have other concurrent anxiety disorders, more severe depression, more lethargic and melancholic features and poorer cognitive and physical functioning, quality of life and work and social adjustment. In acute treatment, participants with anxious features received comparatively higher doses of mirtazapine and venlafaxine and reported more side-effects. The groups with and without anxious features did not differ in treatment outcomes and side-effect burden. Despite being associated with a distinct clinical profile, baseline anxious features were not clinically useful in predicting acute treatment outcomes or differential treatment response.

KW - Anxiety

KW - depression

KW - outcomes

KW - treatment prediction

UR - http://www.scopus.com/inward/record.url?scp=84867249941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867249941&partnerID=8YFLogxK

U2 - 10.1017/S1461145711001660

DO - 10.1017/S1461145711001660

M3 - Article

C2 - 22129562

AN - SCOPUS:84867249941

VL - 15

SP - 1387

EP - 1399

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 10

ER -